New Street Investor Relations: Helping Biotechs Navigate the Complexities of Wall Street.
 
What We Do:

At New Street IR, we specialize in advising public and private biotech companies on their financing and communications strategies to optimize fundraising opportunities and create long term value for stakeholders. With a team of seasoned experts and a comprehensive portfolio of services, we are driven by data, pragmatic advice, and a friendly and collaborative approach.

Our Expertise:

New Street IR brings together a multidisciplinary team of professionals with extensive experience in biotechnology, pharmaceuticals, and specialty pharma. Our consultants collectively have decades of experience on Wall Street, at agencies,  or in-house with public and private companies. This diverse expertise allows us to provide comprehensive solutions tailored to the unique needs of our clients.

Our Vision:

Our CEO & Founder, Laurence Watts, started New Street IR with the goal of providing clients with a high-touch, jargon-free offering that demystifies Wall Street and maximizes a biotech’s chance to succeed. We are passionate about advancing the frontiers of biotechnology and are committed to supporting our clients in their journey to bring groundbreaking therapies and technologies to the patients who need them.

Biotechnology

Investment Management

Life Sciences

New Street Investor Relations

New Street Investor Relations' headquarters in San Diego, United States

New Street Investor Relations

Org chart

Teams

Offices

Similar companies